Index
Grant: Ten30 Biosciences — General Support (Coefficient Giving → Ten30 Biosciences)
Verdictconfirmed95%
1 check · 8/3/20261 → confirmed
Our claim
entire record- Name
- Ten30 Biosciences — General Support
- Amount
- $5,000,000
- Currency
- USD
- Date
- April 2025
- Notes
[Scientific Research] Open Philanthropy recommended an investment of $5,000,000 in Ten30 Biosciences for general support. Ten30 Biosciences is a biotechnology company that is developing a novel oral drug to treat sickle cell disease, using an in-house platform that leverages AI a… expand
[Scientific Research] Open Philanthropy recommended an investment of $5,000,000 in Ten30 Biosciences for general support. Ten30 Biosciences is a biotechnology company that is developing a novel oral drug to treat sickle cell disease, using an in-house platform that leverages AI and chemistry to discover therapeutics for challenging diseases. This falls within our focus area of scientific research.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 8/3/2026
- Name
- Ten30 Biosciences — General Support
- Grantee
- Ten30 Biosciences
- Focus Area
- Scientific Research
- Amount
- $5,000,000.00
- Date
- April 2025
- Description
- Open Philanthropy recommended
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № auCg3yJBF7Filed 8/3/2026Confidence 95%